Eurofins Scientific SE (ERFSF)
OTCMKTS · Delayed Price · Currency is USD
73.45
+2.99 (4.24%)
Oct 10, 2025, 3:51 PM EDT
Eurofins Scientific SE Revenue
Eurofins Scientific SE had revenue of 3.61B EUR in the half year ending June 30, 2025, with 12.54% growth. This brings the company's revenue in the last twelve months to 7.14B, up 6.25% year-over-year. In the year 2024, Eurofins Scientific SE had annual revenue of 6.95B with 6.70% growth.
Revenue (ttm)
7.14B EUR
Revenue Growth
+6.25%
P/S Ratio
1.52
Revenue / Employee
113.95K EUR
Employees
62,696
Market Cap
12.77B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.95B | 436.40M | 6.70% |
Dec 31, 2023 | 6.51B | -197.50M | -2.94% |
Dec 31, 2022 | 6.71B | -5.60M | -0.08% |
Dec 31, 2021 | 6.72B | 1.28B | 23.51% |
Dec 31, 2020 | 5.44B | 876.00M | 19.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
AMJ Global Technology | 39.00 |
Eurofins Scientific SE News
- 8 days ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 12 days ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 17 days ago - Eurofins Scientific SE: Director/PDMR Shareholding - Business Wire
- 18 days ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 19 days ago - Eurofins Scientific SE: Weekly Report on Share Repurchases From 15th September to 19th September 2025 • news - Onvista
- 26 days ago - Eurofins Scientific SE: Weekly Report on Share Repurchases from 08th September to 12th September 2025 • news - Onvista
- 6 weeks ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 2 months ago - What Worked In Q2: Longleaf's Most Impactful Global Holdings - Seeking Alpha